Diabetes expenses have decreased, but are still high

By Kathryn Doyle NEW YORK (Reuters Health) – Out-of-pocket expenses for diabetes treatment have gone down for many U.S. patients over the past decade, according to a new study. But nearly a quarter of people with diabetes still face high expenses. In particular, “(out-of-pocket) expenses declined in the people with public insurance and in people with low income between 2001 and 2011,” mostly because prescription drug costs went down, Rui Li told Reuters Health by email. Li led the study at the Division of Diabetes Translation, part of the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention in Atlanta, Georgia.